Key result
Urotensin II promoted LTB4 release and increased 5-lipoxygenase expression in a concentration- and time-dependent manner in RAW264.7 macrophages via the UT-ROS-Akt pathway.
Urotensin II promotes pro-inflammatory LTB4 secretion in macrophages via the UT-ROS-Akt pathway, highlighting a potential mechanism underlying atherosclerosis.
Answers are grounded in this paper and cite their sources.
May inform macrophage inflammation mechanisms; leaves open clinical relevance for cardiovascular disease.
INTRODUCTION: ) production by macrophages. MATERIAL AND METHODS: and 5-lipoxygenase expression was assayed by enzyme-linked immunosorbent assay and Western blot, respectively. Western blot analysis was also employed to determine the phosphorylated forms of Akt. Reactive oxygen species (ROS) level was detected by the fluorescent probe 2',7'-dichlorofluorescin diacetate and fluorescence intensity was measured with a multiwell fluorescence plate reader. RESULTS: release and increased 5-lipoxygenase expression in a concentration- and time-dependent manner in RAW264.7 cells. Leukotriene B4 production and 5-lipoxygenase expression were decreased by blocking the UII receptor (UT) with urantide, eliminating ROS with N-acetylcysteine and diphenyliodonium, and inhibiting Akt phosphorylation with LY294002. UII significantly elevated ROS production, whereas urantide, N-acetylcysteine and diphenyliodonium substantially attenuated this effect. UII also enhanced Akt phosphorylation significantly, and this effect was potently inhibited by urantide, N-acetylcysteine, diphenyliodonium and LY294002. CONCLUSIONS: release in RAW264.7 macrophages via UT-ROS-Akt pathways. These results indicate that UII may participate in macrophage activation and suggest a potential new mechanism underlying atherosclerosis.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2019) studied Atherosclerosis (in vitro model). Urotensin II vs. Untreated control was evaluated on LTB4 release and 5-lipoxygenase expression (p=<0.01). Urotensin II promoted LTB4 release and increased 5-lipoxygenase expression in a concentration- and time-dependent manner in RAW264.7 macrophages via the UT-ROS-Akt pathway.
Synapse has enriched 10 related papers. Consider them for comparative context: